Indian Pharmaceutical companies, from Sun Pharma Ltd., to Lupin Ltd., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Ltd., Gland Pharma Ltd., will be reacting on Wednesday, April 9, after US President Donald Trump said that he will be announcing major tariffs on the Pharma sector soon. Speaking at the Republican NRCC event, Trump said that major […]
Pharma Stocks Crash: Donald Trump says tariffs will be at ‘never seen before’ levels – CNBC TV18
Shares of Indian Pharma Companies, Aurobindo Pharma, IPCA Laboratories, Lupin and others fell up to 5% on Friday, April 4, after US President Donald Trump remarked about the upcoming tariffs on the sector. “Pharma tariffs are going to come in at levels you have never seen before. We are looking at pharmaceuticals as a separate […]
Bonus, Dividend, Stock Split Alert: Important corporate actions for next week – CNBC TV18
1 / 12 Multiple companies who have declared dividends along with their quarterly results and those who had earlier announced bonus shares or stock splits will face their respective record dates during the upcoming week. Here is a look at some of those companies. 2 / 12 Redtape | The demerged entity of footwear brand […]
Sun Pharma analysts see stock testing ₹2,400 levels; Should you buy or sell? – CNBC TV18
Shares of Sun Pharmaceutical Industries Ltd., India’s largest drugmaker, opened with gains of as much as 3% on Saturday, February 1, and are the top gainers on the Nifty 50 index after the company reported its December quarter results. Company Value Change %Change Sun Pharma’s US formulation sales was at $474 million during the quarter. […]
Stocks to Watch on February 1: ONGC, Sun Pharma, LIC Housing Finance, IndusInd Bank and more – CNBC TV18
1 / 17 ONGC | The company reported a net profit of ₹8,240 crore in Q3FY25, significantly lower than the CNBC-TV18 poll estimate of ₹9,484 crore. On a quarter-on-quarter (QoQ) basis, net profit declined 31.2% from ₹11,984 crore in Q2 FY25. The PSU oil giant’s revenue stood at ₹33,716.8 crore, marginally down 0.5% QoQ from […]
Trade Setup for January 31: 20-DMA remains a hurdle for the Nifty ahead of Union Budget – CNBC TV18
The market exhibited high volatility on the monthly expiry day but managed to extend its winning streak for the third consecutive session. After opening on a positive note, the market moved higher in the early part of the session. Intraday volatility occurred in the mid-session, but the markets ended largely higher. Company Value Change %Change […]
Ambuja Cements, Sun Pharma, Indus Towers and Eicher Motors are analysts’ top buy choices for today – CNBC TV18
1 / 7 Technical analyst Mitessh Thakkar of earningwaves.com share these top stock picks for the day. 2 / 7 Buy for a target price of ₹566 with a stop loss of ₹540 Analyst: Mitessh Thakkar of earningwaves.com at 9:15 am 3 / 7 Buy for a target price of ₹1,875 with a stop loss […]
Tech analysts see upside in SRF, LTTS, Biocon, RIL and Apollo Hospitals – CNBC TV18
1 / 13 Technical analysts Mitessh Thakkar of earningwaves.com, Shrikant Chouhan of Kotak Securities and Futures and Options analyst Chandan Taparia, Derivative and Technical Analyst at Motilal Oswal Financial Services share these top stock picks for the day. 2 / 13 Buy for a target price of ₹2,720 with a stop loss of ₹2,560 Analyst: […]
Elara Securities expects earnings upgrades for these pharma stocks – CNBC TV18
Bino Pathiparampil, Head of Research at Elara Securities (India), listed the brokerage’s top picks from the pharma sectors that are expected to benefit the most from a falling rupee. “The depreciation in rupee is going to help almost all the players, especially the large players who have big presences in the US. So that includes […]
What is the Nifty target for 2025? Jefferies shares its top picks – CNBC TV18
Brokerage firm Jefferies has a target of 26,600 for the Nifty 50 index for the calendar year 2025. The target implies a potential upside of 10% from current levels on the Index. Company Value Change %Change The brokerage said that the one-year forward price-to-earnings multiple for the Nifty is trading above its five-year average and […]